Literature DB >> 27714440

Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.

E Kamycheva1,2,3, T Goto4,5, C A Camargo4,5.   

Abstract

We investigated the association between celiac disease (CD) and bone mass density (BMD) and risk of osteoporotic fractures in the general US population. In children and men ≥18 years, CD was associated with reduced BMD, and in men ≥40 years, CD was associated with increased risk of osteoporotic fractures.
INTRODUCTION: Celiac disease (CD) is an autoimmune condition, characterized by inflammation of the small intestine. CD has an increasing prevalence, and if unrecognized or untreated, CD can lead to complications from malabsorption and micronutrient deficiencies. We aimed to study whether CD is an independent predictor of reduced bone mineral density (BMD) and FRAX scores in the general US population.
METHODS: We used data from the National Health and Nutrition Examination Survey, 2009-2010 and 2013-2014. CD was defined by positive tissue transglutaminase IgA antibody test. Multivariable models of BMD and FRAX scores were adjusted for BMI, serum 25-hydroxyvitamin D, vitamin D and calcium supplements, milk intake, serum calcium, and smoking status, when available.
RESULTS: In children, aged 8-17 years, CD was associated with decreased Z-scores, by 0.85 for hip and 0.46 for spine (both P < 0.001). In men aged ≥ 18 years, CD was associated with 0.06 g/cm2 decrease in BMD in hip and with 0.11 g/cm2 decrease in BMD in spine (P = 0.08 and P < 0.001, respectively). In women, there were no statistically significant differences in the multiple-adjusted model. In men aged ≥ 40 years, CD predicted FRAX scores, resulting in increased scores by 2.25 % (P = 0.006) for hip fracture and by 2.43 % (P = 0.05) for major osteoporotic fracture. CD did not predict FRAX scores in women aged ≥40 years.
CONCLUSION: CD is independently associated with reduced BMD in children and adults aged ≥18 years and is an independent risk factor of osteoporotic fractures in men aged ≥40 years.

Entities:  

Keywords:  Bone mineral density; Celiac disease; FRAX score; NHANES; Osteoporosis

Mesh:

Year:  2016        PMID: 27714440     DOI: 10.1007/s00198-016-3791-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  A revised clinician's guide to the prevention and treatment of osteoporosis.

Authors:  Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

Review 2.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

Review 3.  Inflammatory bowel diseases, celiac disease, and bone.

Authors:  Maria Luisa Bianchi
Journal:  Arch Biochem Biophys       Date:  2010-06-30       Impact factor: 4.013

4.  Osteoporosis in men: the value of laboratory testing.

Authors:  C S Ryan; V I Petkov; R A Adler
Journal:  Osteoporos Int       Date:  2010-10-09       Impact factor: 4.507

5.  Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects.

Authors:  Julia Beilfuss; Vivian Berg; Monica Sneve; Rolf Jorde; Elena Kamycheva
Journal:  Cytokine       Date:  2012-08-24       Impact factor: 3.861

6.  Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the Generation R Study.

Authors:  Michelle A E Jansen; Jessica C Kiefte-de Jong; Romy Gaillard; Johanna C Escher; Albert Hofman; Vincent W V Jaddoe; Herbert Hooijkaas; Henriette A Moll
Journal:  Clin Gastroenterol Hepatol       Date:  2014-09-22       Impact factor: 11.382

7.  Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women.

Authors:  Daniel Agardh; Sara Björck; Carl-David Agardh; Jonas Lidfeldt
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

8.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

Review 9.  Immunology of Osteoporosis: A Mini-Review.

Authors:  Peter Pietschmann; Diana Mechtcheriakova; Anastasia Meshcheryakova; Ursula Föger-Samwald; Isabella Ellinger
Journal:  Gerontology       Date:  2015-06-17       Impact factor: 5.140

10.  Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements.

Authors:  Freek J B Lötters; Joop P van den Bergh; Frank de Vries; Maureen P M H Rutten-van Mölken
Journal:  Calcif Tissue Int       Date:  2016-01-09       Impact factor: 4.333

View more
  11 in total

Review 1.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

2.  [Hip fracture due to osteomalacia secondary to celiac disease]

Authors:  Alberto Hernández Fernández; Cristian Pinilla-Gracia; Luis Rodríguez Nogué; Luis Rodríguez Chacón; Carlos Bejarano Lasunción
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2022-03-07

Review 3.  Celiac Disease-Musculoskeletal Manifestations and Mechanisms in Children to Adults.

Authors:  Haley M Zylberberg; Benjamin Lebwohl; Peter H R Green
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

4.  Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis.

Authors:  Li Liu; Weiwei Tao; Wenjia Pan; Li Li; Qiong Yu; Dawei Zhang; Jun Jiang
Journal:  Biomed Res Int       Date:  2018-07-05       Impact factor: 3.411

Review 5.  Celiac disease: a comprehensive current review.

Authors:  Giacomo Caio; Umberto Volta; Anna Sapone; Daniel A Leffler; Roberto De Giorgio; Carlo Catassi; Alessio Fasano
Journal:  BMC Med       Date:  2019-07-23       Impact factor: 8.775

Review 6.  Nutrition in Patients with Lactose Malabsorption, Celiac Disease, and Related Disorders.

Authors:  Michele J Alkalay
Journal:  Nutrients       Date:  2021-12-21       Impact factor: 5.717

7.  Fracture risk assessment in celiac disease: a registry-based cohort study.

Authors:  D R Duerksen; L M Lix; H Johansson; E V McCloskey; N C Harvey; J A Kanis; W D Leslie
Journal:  Osteoporos Int       Date:  2020-08-03       Impact factor: 4.507

8.  Pediatric Reference Intervals for Biochemical Markers: Gaps and Challenges, Recent National Initiatives and Future Perspectives.

Authors:  Houman Tahmasebi; Victoria Higgins; Angela W S Fung; Dorothy Truong; Nicole M A White-Al Habeeb; Khosrow Adeli
Journal:  EJIFCC       Date:  2017-03-08

9.  25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease.

Authors:  Carolina Ciacci; Giancarlo Bilancio; Ilaria Russo; Paola Iovino; Pierpaolo Cavallo; Antonella Santonicola; Cristina Bucci; Massimo Cirillo; Fabiana Zingone
Journal:  Nutrients       Date:  2020-03-27       Impact factor: 5.717

Review 10.  The Progression of Celiac Disease, Diagnostic Modalities, and Treatment Options.

Authors:  Zahid Ijaz Tarar; Muhammad Usman Zafar; Umer Farooq; Omer Basar; Veysel Tahan; Ebubekir Daglilar
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.